Metacognitive Strategy Help for Parkinson’s-Related Thinking Difficulties

Who could benefit from this research

What this research studies

If you have Parkinson’s and experience cognitive difficulties, this study tests a strategy-based program called Multicontext to help you use practical tricks in daily activities. The researchers will guide participants through training that teaches generalizable strategies to cope with thinking and memory problems, with emphasis on applying them to real-life tasks. The study will compare outcomes to see if this approach reduces disability and helps people stay engaged in work, home duties, and social roles. Participation may involve cognitive training sessions and assessments of daily functioning over time. The aim is to translate cognitive support into meaningful improvements in day-to-day life for people living with PD.

Why it matters

Where this research is happening

• Washington University
  Saint Louis, United States Active

Researchers

• Principal investigator: Foster, Erin — Washington University
• Study coordinator: Foster, Erin

Related research

Other NIH-funded projects on the same topics.

• Improving memory function in people with Parkinson's disease

  This study is all about helping people with Parkinson's disease who are having trouble with memory and daily tasks by teaching them practical tips they can use in their everyday lives to feel more confident and improve their quality of life.

  NIH research Washington University · Saint Louis, United States · NIH-11128930

• Improving memory function in people with Parkinson's disease-related cognitive decline

  This study is all about helping people with Parkinson's disease who are having trouble remembering daily tasks by teaching them new strategies to manage their activities better, so they can enjoy life more and possibly slow down memory issues.

  NIH research Washington University · Saint Louis, United States · NIH-10886048

• How COVID-19 infection and genes may influence memory and dementia risk

  This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.

  NIH research University of Texas Hlth Science Center · San Antonio, United States · NIH-11617103

• NGF Metabolism as a biomarker for cognitive decline in familial Alzheimer's disease

  Researchers are studying whether patterns in nerve growth factor pathways in blood and CSF can signal early, preclinical stages of Alzheimer's in people with genetic risk.

  NIH research Boston University (Charles River Campus) · Boston, United States · NIH-11597025

• NGF metabolism as an early biomarker for cognitive decline in familial Alzheimer's disease

  This project tests whether NGF pathway proteins in blood and CSF can signal early, preclinical changes in people with familial Alzheimer’s disease.

  NIH research Boston University (Charles River Campus) · Boston, United States · NIH-11597016

• NGF Metabolic Dysfunction as a Marker of Cognitive Decline in Autosomal Dominant Alzheimer's Disease

  This project looks at nerve growth factor pathways in people with a genetic form of Alzheimer's to see if blood and spinal fluid markers can identify early brain changes before symptoms appear.

  NIH research Boston University (Charles River Campus) · Boston, United States · NIH-11591274

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.